EUVIMEDEUVIMED entdecken
Open Access

Acetylsalicylic acid use and development of cardiac allograft vasculopathy: A national prospective study using highly automated 3‐D optical coherence tomography analysis

Lucie Mayerova iD, Peter Wohlfahrt, Milan Sonka, Zhi Chen, Josef Kautzner, Vojtech Melenovsky, Vladimir Karmazin, Ivan Malek, Helena Bedanova, Ales Tomasek, Eva Ozabalova, Jan Krejci und 2 weitere

Clinical Transplantation · 2024

DOI: 10.1111/ctr.15275 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Transplantation, 2024. Verfasst von Lucie Mayerova und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, IKEM, Prague, Czech Republic. Hauptthemen laut MEDLINE: Coronary Artery Disease, Plaque, Atherosclerotic, Heart Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIBIB NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is conflicting evidence on the role of acetylsalicylic acid (ASA) use in the development of cardiac allograft vasculopathy (CAV).

Methods

A nationwide prospective two‐center study investigated changes in the coronary artery vasculature by highly automated 3‐D optical coherence tomography (OCT) analysis at 1 month and 12 months after heart transplant (HTx). The influence of ASA use on coronary artery microvascular changes was analyzed in the overall study cohort and after propensity score matching for selected clinical CAV risk factors.

Results

In total, 175 patients (mean age 52 ± 12 years, 79% male) were recruited. During the 1‐year follow‐up, both intimal and media thickness progressed, with ASA having no effect on its progression. However, detailed OCT analysis revealed that ASA use was associated with a lower increase in lipid plaque (LP) burden ( p = .013), while it did not affect the other observed pathologies. Propensity score matching of 120 patients (60 patient pairs) showed similar results, with ASA use associated with lower progression of LPs ( p = .002), while having no impact on layered fibrotic plaque ( p = .224), calcification ( p = .231), macrophage infiltration ( p = .197), or the absolute coronary artery risk score ( p = .277). According to Kaplan–Meier analysis, ASA use was not associated with a significant difference in survival ( p = .699)

Conclusion

This study showed a benefit of early ASA use after HTx on LP progression. However, ASA use did not have any impact on the progression of other OCT‐observed pathologies or long‐term survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseasePlaque, AtheroscleroticHeart TransplantationHumansMaleAdultMiddle AgedFemaleProspective StudiesTomography, Optical CoherenceAllograftsCoronary Angiography

Stichwörter der Autor:innen

OCTacetylsalicylic acidcardiac allograft vasculopathylipid plaque

Autor:innen und Institutionen

  • Department of Cardiology, IKEM, Prague, Czech Republic.
  • Department of Preventive Cardiology, IKEM, Prague, Czech Republic.
  • Iowa Institute for Biomedical Imaging, The University of Iowa, Iowa City, Iowa, USA.
  • Cardiovascular and Transplantation Surgery, Brno, Czech Republic.
  • Department of Cardiovascular Diseases, St. Anne's University Hospital and Masaryk University Brno, Brno, Czech Republic.
  • 2nd Department of Internal Medicine, Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.

ORCID-Profile: Lucie Mayerova

Förderung

  • NIBIB NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Mayerova, L., Wohlfahrt, P., Sonka, M., Chen, Z., Kautzner, J., Melenovsky, V., Karmazin, V., Malek, I., Bedanova, H., Tomasek, A., Ozabalova, E., Krejci, J., Kovarnik, T., & Pazdernik, M. (2024). Acetylsalicylic acid use and development of cardiac allograft vasculopathy: A national prospective study using highly automated 3‐D optical coherence tomography analysis. Clinical Transplantation. https://doi.org/10.1111/ctr.15275

Vancouver

Mayerova L, Wohlfahrt P, Sonka M, Chen Z, Kautzner J, Melenovsky V, et al. Acetylsalicylic acid use and development of cardiac allograft vasculopathy: A national prospective study using highly automated 3‐D optical coherence tomography analysis. Clinical Transplantation. 2024. doi:10.1111/ctr.15275

BibTeX
@article{Mayerova2024,
  author = {Mayerova, Lucie and Wohlfahrt, Peter and Sonka, Milan and Chen, Zhi and Kautzner, Josef and Melenovsky, Vojtech and Karmazin, Vladimir and Malek, Ivan and Bedanova, Helena and Tomasek, Ales and Ozabalova, Eva and Krejci, Jan and Kovarnik, Tomas and Pazdernik, Michal},
  title = {Acetylsalicylic acid use and development of cardiac allograft vasculopathy: A national prospective study using highly automated 3‐D optical coherence tomography analysis},
  journal = {Clinical Transplantation},
  year = {2024},
  doi = {10.1111/ctr.15275}
}
Kostenlos starten →